[Pulmonary hemorrhage in rheumatic diseases]
1I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University).
Terapevticheskii Arkhiv
|June 30, 2020
Summary
This review examines pulmonary hemorrhage (PH) causes, focusing on rheumatic disease patients. It analyzes diagnostic methods and current therapeutic strategies for PH.
Area of Science:
- Rheumatology
- Pulmonology
- Internal Medicine
Background:
- Pulmonary hemorrhage (PH) is a serious condition with diverse etiologies.
- Rheumatic diseases are an important, often overlooked, cause of PH.
- Accurate diagnosis and timely treatment are crucial for patient outcomes.
Purpose of the Study:
- To comprehensively review the causes of pulmonary hemorrhage (PH).
- To highlight the specific challenges and considerations for PH in patients with rheumatic diseases.
- To analyze current diagnostic techniques and therapeutic interventions for PH.
Main Methods:
- Literature review of existing data on pulmonary hemorrhage.
- Analysis of clinical experience with PH patients, particularly those with rheumatic conditions.
- Evaluation of diagnostic modalities and treatment protocols for PH.
Main Results:
- Identified various causes of PH, with a focus on rheumatological associations.
- Detailed the diagnostic approaches, including imaging and laboratory tests.
- Summarized modern treatment strategies, including immunosuppressive therapy and supportive care.
Conclusions:
- Pulmonary hemorrhage in rheumatic disease requires a high index of suspicion.
- Multidisciplinary approaches improve diagnostic accuracy and treatment efficacy.
- Advances in therapy offer improved prognoses for PH patients.
More Related Videos
Related Concept Videos
01:23Rheumatic Heart Disease I: Introduction
301
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
301
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
314
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
314
01:20Rheumatic Heart Disease IV: Nursing Management
182
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
182
01:21Rheumatic Heart Disease III: Medical Management
185
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
185
01:29Pulmonary Embolism I: Introduction
386
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
386
01:30Pulmonary Hypertension: Classification and Pathogenesis
479
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
479